CCR5 and pancreatic neoplasm: Pancreatic tumors that are poorly differentiated produce higher levels of CCL5 and express more of its main receptor, CCR5, compared to well-differentiated and non-cancerous tissue (Monti et al., 2004; Singh et al., 2018).